Is BioLife Solutions, Inc. (NASDAQ:BLFS) Trading At A 34% Discount?

Simply Wall StJan 24 18:41

Lake Street Maintains BioLife Solutions(BLFS.US) With Buy Rating, Maintains Target Price $30

Futu NewsJan 14 22:31 · Ratings

BioLife Solutions Reports $22.7M Q4 Revenue Up 31%; Cell Processing Platform Up 37%, Evo And Thaw Platform Down 8%; Full Year Revenue At $82.3M, Up 8%; Cell Processing Up 12%, Evo And Thaw Down 14%

BenzingaJan 13 22:17

BioLife Solutions: 4Q Cell Processing Rev Rose 7% Sequentially to $20.3M

Dow JonesJan 13 21:35

Express News | BioLife Solutions Q4 Revenue USD 20.3 Million Vs. IBES Estimate USD 21.5 Million

BreakingsJan 13 21:30

Press Release: BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2024 Unaudited Revenue From Continuing Operations

Dow JonesJan 13 21:30